Preview

Вопросы современной педиатрии

Расширенный поиск

ПРИНЦИПЫ АНТИБАКТЕРИАЛЬНОЙ ТЕРАПИИ СТРЕПТОКОККОВОГО ТОНЗИЛЛОФАРИНГИТА

https://doi.org/10.15690/vsp.v13i2.976

Полный текст:

Аннотация

Острый тонзиллофарингит является одной из наиболее распространенных внебольничных инфекций. До 20–30% случаев заболевания в педиатрической практике обусловлены β-гемолитическим стрептококком группы А и требуют обязательной системной антибактериальной терапии с целью купирования симптоматики и ограничения очага инфекции, а также для профилактики гнойных и аутоиммунных осложнений (острая ревматическая лихорадка и др.). Несмотря на высокую чувствительность β-гемолитического стрептококка группы А к пенициллину in vitro, зачастую имеет место рецидивирующее течение заболевания как следствие отсутствия эрадикации возбудителя при стартовой пенициллинотерапии или реинфекции. В связи с этим приводится анализ как причин клинической и/или бактериологической неэффективности лечения, так и путей их преодоления, в т.ч. с помощью альтернативных антибактериальных препаратов.

Об авторе

Д. П. Поляков
Научный центр здоровья детей, Москва
Россия


Список литературы

1. Belov B. S. Consilium medicum (Infektsii i antimikrobnaya terapiya — Infections and Antimicrobic Therapy). 2000; 2 (2): 164–168.

2. Shulman S. T., Bisno A. L., Clegg H. W., Gerber M. A., Kaplan E. L., Lee G., Martin J. M., Van Beneden C. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2012; 55 (10): 1279–82.

3. Bisno A. L. Acute pharyngitis: etiology and diagnosis. Pediatrics. 1996; 97: 949–954.

4. Ebell M. H., Smith M. A., Barry H. C., Ives K., Carey M. The rational clinical examination. Does this patient have strep throat? JAMA. 2000; 284: 2912–2918.

5. Darmanyan A. S. Sovershenstvovaniye metodov diagnostiki i lecheniya ostrykh tonzillitov u detey [Improvement of Methods of Diagnostics and Treatment of Quinsy at Children]. Synopsis of thesis for the degree of Candidate of Medical Science. М. 2010. 23 p.

6. Bista M., Amatya R. C., Basnet P. Tonsillar microbial flora: a comparison of infected and non-infected tonsils. Kathmandu Univ. Med. J. 2006; 4 (1): 18–21.

7. Esposito S., Bosis S., Begliatti E., Droghetti R., Tremolati E., Tagliabue C., Bellasio M., Blasi F., Principi N. Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy. Clin. Infect. Dis. 2006; 43 (2): 206–209.

8. Boccazzi A., Garotta M., Pontari S., Agostoni C. V. Streptococcal tonsillopharyngitis: clinical vs. microbiological diagnosis. Infez. Med. 2011; 19 (2): 100–105.

9. Starovoytova Ye. V., Fedorov A. M., Botvinyeva V. V., Tatochenko V. K., Bakradze M. D., Darmanyan A. S. Pediatricheskaja farmakologija — Pediatric pharmacology. 2007; 3 (4): 45–49.

10. Darmanyan A. S. Pediatricheskaja farmakologija — Pediatric pharmacology. 2007; 6 (4): 28.

11. McIsaac W. J., Goel V., To T., Low D. E. The validity of sore throat score in family practice. CMAJ. 2000; 163 (7): 811–815.

12. Polyakov D. P. Voprosi sovremennoi pediatrii — Current Pediatrics. 2013; 12 (3): 46–51.

13. Bogdanovich T. M. Klinicheskiye i farmakodinamicheskiye osobennosti ispol'zovaniya makrolidnykh antibiotikov pri ostrom streptokokkovom tonzillite [Clinical and Pharmacodynamic Properties of Use of Macrolide Antibiotics at Acute Streptococcal Tonsillitis]. Synopsis of thesis for the degree of Candidate of Medical Science. Smolensk. 2003. 20 p.

14. Chiappini E., Regoli M., Bonsignori F., Sollai S., Parretti A., Galli L., de Martino M. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin. Ther. 2011; 33 (1): 48–58.

15. Pelucchi C., Grigoryan L., Galeone C., Esposito S., Huovinen P., Little P., Verheij T. ESCMID Guideline for the Management of Acute Sore Throat. Clin. Microbiol. Infect. 2012; 18 (Suppl. 1): 1–27.

16. Feder H. M., Jr., Gerber M. A., Randolph M. F., Stelmach P. S., Kaplan E. L. Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics. 1999; 103: 47–51.

17. Bisno A. L., Gerber M. A., Gwaltney J. M., Jr, Kaplan E. L., Schwartz R. H. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin. Infect. Dis. 2002; 35: 113–125.

18. Lennon D., Peat N., Kerdemelidis M., Wilson N., Arroll B., AtatoaCarr P. Group A Streptococcal Sore Throat Management. Evidencebased, best practice New Zealand Guidelines for Rheumatic Fever. Auckland, The National Heart Foundation of New Zealand. 2008. 64 p.

19. Denny F. W., Wannamaker L. W., Brink W. R., Rammelkamp C. H., Jr., Custer E. A. Prevention of rheumatic fever; treatment of the preceding streptococcic infection. J. Am. Med. Assoc. 1950; 143 (2): 151–153.

20. Wannamaker L. W., Rammelkamp C. H., Jr., Denny F. W., Brink W. R., Houser H. B., Hahn E. O., Dingle J. H. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am. J. Med. 1951; 10 (6): 673–695.

21. Pichichero M. E. The rising incidence of penicillin treatment failures in group A streptococcal tonsillopharyngitis: an emerging role for the cephalosporins? Ped. Infect. Dis. J. 1991; 10: 50–55.

22. Pichichero M. E., Casey J. R. Systematic review of factors contributing to penicillin treatment failure in Streptococcus pyogenes pharyngitis. Otolaryngol. Head Neck Surg. 2007; 137 (6): 851–857.

23. Lafontaine E. R., Wall D., Vanlerberg S. L., Donabedian H., Sledjeski D. D. Moraxella catarhalis coaggregates with Streptococcus pyogenes and modulates interactions of S. pyogenes with human epithelial cells. Infect. Immun. 2004; 72 (11): 6689–6693.

24. Sundberg L., Eden T., Ernstson S. The penetration of erythromycin into Waldeyer’s ring — tonsoll and adenoid tissue. Infection. 1982; 10 (Suppl. 2): 102–104.

25. Jetlund O., Thurmann-Nielsen E., Walstad R. A. Comparison of the serum and tissue concentrations of cefuroxime from cefuroxim axetil and phenoxymethylpenicillin in patients undergoing tonsillectomy. Int. J. Clin. Pharmacol. Res. 1991; 11 (1): 1–6.

26. Bugrysheva J., Froehlich B. J., Freiberg J. A., Scott J. R. Serine/ threonine protein kinase Stk is required for virulence, stress response, and penicillin tolerance in Streptococcus pyogenes. Infect. Immun. 2011; 79 (10): 4201–4209.

27. Tatochenko V. K. Antibiotiko- i khimioterapiya infektsiy u detey [Antibiotic and Chemical Therapy of Infections at Children]. М.: Kontinent-Press. 2008. 256 p.

28. Roos K., Holm S. E., Grahn E., Lind L. Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study. Scand. J. Inf. Dis. 1993; 25 (1): 31–35.

29. Roos K., Holm S. E., Grahn-Hakansson E., Laqerqren L. Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis — a randomized placebo-controlled multicentre study. Scand. J. Infect. Dis. 1996; 28 (5): 459–462.

30. Di Pierro F., Donato G., Fomia F., Adami T., Carredu D., Cassandro C., Albera R. Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent otitis media. Int. J. Gen. Med. 2012; 5: 991–997.

31. Alcaide F., Linares J., Pallares R., Carratala J., Benitez M. A., Gudiol F., Martin R. In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob. Agents Chemother. 1995; 39 (10): 2243–2247.

32. Bergman A., Werner R. Failure of children to receive penicillin by mouth. N. Engl. J. Med. 1963; 268: 1334–1338.

33. Scholz H. Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. Results depending on children’s age. Chemotherapy. 2004; 50 (1): 51–54.

34. Adam D., Scholz H., Helmerking M. Treatment of group A streptococcal tonsillopharyngitis. 5 days cephalosporin is as effective as 10 days penicillin. MMW Fortschr. Med. 2001; 143 (18): 40.

35. Canton R., Loza E., Morosini M., Baquero F. Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999–2000. J. Antimicrob. Chemother. 2002; 50 (Suppl. 1): 9–24.

36. Sidorenko S. V. Consilium medicum. 2002; 4 (1): 4–9.

37. d'Humieres C., Cohen R., Levy C., Bidet P., Thollot F., Wollner A., Bingen E. Decline in macrolide-resistant Streptococcus pyogenes isolates from French children. Int. J. Med. Microbiol. 2012; 302 (7–8): 300–303. 3

38. Van Driel M. L., De Sutter A. I. M., Keber N., Habraken H., Christiaens T. Different antibiotic treatments for group A streptococcal pharyngitis (Review). Evid.-Based Child Health: A Cochr. Rev. J. 2011; 7 (1): 16–81.

39. Campagna J. D., Bond M. C., Schabelman E., Hayes B. D. The use of cephalosporins in penicillin-allergic patients: a literature review. J. Emerg. Med. 2012; 42 (5): 612–620.


Для цитирования:


Поляков Д.П. ПРИНЦИПЫ АНТИБАКТЕРИАЛЬНОЙ ТЕРАПИИ СТРЕПТОКОККОВОГО ТОНЗИЛЛОФАРИНГИТА. Вопросы современной педиатрии. 2014;13(2):83-88. https://doi.org/10.15690/vsp.v13i2.976

For citation:


Polyakov D.P. РRINCIPLES OF ANTIBACTERIAL THERAPY OF STREPTOCOCCAL TONSILLOPHARYNGITIS. Current Pediatrics. 2014;13(2):83-88. (In Russ.) https://doi.org/10.15690/vsp.v13i2.976

Просмотров: 452


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)